SGRY:NSD-Surgery Partners Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 22.75

Change

+0.92 (+4.21)%

Market Cap

USD 3.65B

Volume

3.09M

Analyst Target

USD 21.83
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-19 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

+0.24 (+0.17%)

USD 8.88B
OPCH Option Care Health Inc

+0.08 (+0.37%)

USD 4.10B
ACHC Acadia Healthcare Company Inc

-0.04 (-0.11%)

USD 3.45B
AMED Amedisys Inc

+0.55 (+0.61%)

USD 2.97B
LFST Lifestance Health Group Inc

+0.23 (+3.28%)

USD 2.61B
ADUS Addus HomeCare Corporation

+1.93 (+1.63%)

USD 2.21B
ASTH Astrana Health Inc

+0.42 (+1.04%)

USD 1.87B
AVAH Aveanna Healthcare Holdings In..

+0.11 (+1.93%)

USD 1.08B
HCSG Healthcare Services Group Inc

+0.13 (+1.16%)

USD 0.85B
DCGO DocGo Inc

+0.02 (+0.50%)

USD 0.42B

ETFs Containing SGRY

NASH 0.00 % 0.49 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -28.88% 50% F 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -28.88% 50% F 28% F
Trailing 12 Months  
Capital Gain -28.97% 42% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -28.97% 42% F 25% F
Trailing 5 Years  
Capital Gain 79.28% 80% B- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 79.28% 80% B- 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 54.13% 88% B+ 88% B+
Dividend Return 54.13% 88% B+ 87% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 141.46% 19% F 16% F
Risk Adjusted Return 38.26% 77% C+ 69% C-
Market Capitalization 3.65B 92% A 86% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector